Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003620:Dantrolene / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009128:Muscle Spasticity / Q000188:drug therapy / Q000209:etiology; D010243:Paralysis / Q000188:drug therapy* / Q000209:etiology; D013118:Spinal Cord Diseases / Q000150:complications / Q000188:drug therapy*
D006827:Hydantoins; D003620:Dantrolene